Skip to content

Company newsroom

Zura Bio Ltd

NASDAQ:ZURA

1 releases

Zura Bio Ltd3h ago

Zura Bio Provides Clinical Update on Phase 2 TibuSHIELD Study of Tibulizumab (ZB-106) in Hidradenitis Suppurativa

November 9, 2026 7:00 AM

Zura Bio Ltd News & Press Releases | Major Health News